The high failure rate of drugs in human trials after passing animal tests stems from a fundamental biological reality: a "mouse is not a small human." This "structural mismatch" is especially severe for modern, human-specific therapies like CAR-T and RNA, rendering animal models poor proxies.

The multi-hundred-billion-dollar wellness industry has a financial incentive to discredit proven science. A key tactic involves buying cheap, bulk generics like ivermectin, repackaging them, and selling them with massive markups via telehealth, which requires them to portray effective treatments like vaccines as harmful.

Current drug development heavily relies on animal testing. However, significant biological differences mean we may be filtering out effective human medicines that fail in animal models, creating a hidden opportunity cost for medical breakthroughs.

A core flaw in virus hunting is moving pathogens from isolated natural environments to labs in dense population centers. Despite security ratings, all categories of labs have a history of leaks. The lack of a uniform reporting system means we don't know the failure rate, making labs a riskier container than nature.

The rationale for "virus hunting" is to create advance vaccines. However, you cannot safely test a vaccine for a novel, deadly pathogen on healthy humans. This makes the knowledge unactionable for prevention, while creating immense risk by bringing dangerous pathogens into leaky labs and publicizing their existence.

The danger of LLMs in research extends beyond simple hallucinations. Because they reference scientific literature—up to 50% of which may be irreproducible in life sciences—they can confidently present and build upon flawed or falsified data, creating a false sense of validity and amplifying the reproducibility crisis.

The typical path for a new, high-risk biology is to test it in patients with no other options, like in oncology. The COVID-19 pandemic forced a massive deviation from this norm. For the first time, a completely new class of medicine (mRNA) was deployed at scale in healthy individuals, not the sickest.

The widespread medical recommendation for young children to avoid peanut butter until age 3 was tragically wrong. This advice ignited the modern peanut allergy epidemic by preventing the early exposure necessary to build immune tolerance, a complete reversal of correct science.

A patient describes feeling 'amazingly improved' just hours after taking Ivermectin for COVID. This powerful personal experience illustrates why large-scale clinical data showing a drug is ineffective often fails to persuade individuals. A compelling anecdote is frequently more powerful to the person who lived it than any statistic.